Sanguine biosciences DBA plasma
Ended Purchase Order Awarded
- Contract number
- 75D30121P12831
- Awardee
-
Sanguine Biosciences, Inc. UEI K2BANCKDAJJ9
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $108,792
Award facts
- Contract value 100% obligated
- $108,792.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Atlanta, GA 30329, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order contract to Sanguine Biosciences, Inc., a for-profit organization, for $108,792.00. The contract has a completion date of February 28, 2022 and was awarded on September 23, 2021. The place of performance is in Atlanta, GA. No set-aside designation was used for this award.
Quick answers
Who was awarded contract 75D30121P12831?
75D30121P12831 was awarded to Sanguine Biosciences, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 23, 2021.
How much is contract 75D30121P12831 worth?
The government has obligated $108,792 on 75D30121P12831.
Was contract 75D30121P12831 competed?
The extent of competition for 75D30121P12831 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award